Systemic Therapy for Hepatocellular Carcinoma - Guideline Learning Activities - Guideline Central

Systemic Therapy for Hepatocellular Carcinoma

American Gastroenterological Association

Publication Date: February 20, 2022

The Systemic Therapy for Hepatocellular Carcinoma guideline, developed by the American Gastroenterological Association, provides evidence-based recommendations on the use of systemic therapy in the treatment of hepatocellular carcinoma.
6
Questions
8
Minutes Est.
120
Possible Points
Unrated
Difficulty
Objectives
  • Recognizing first-line systemic therapy for HCC in patients with preserved liver function
  • Understanding second-line systemic therapy for HCC in patients with disease progression or intolerance to first-line therapy
  • Identifying systemic therapy options for HCC in patients with poor liver function
  • Learning the role of systemic therapy as adjuvant treatment for HCC
Instructions
Answer All QuestionsYou must answer each question to move forward.
Get Instant FeedbackAfter you submit each answer, you'll receive an explanation.
Progress is Saved AutomaticallyYour progress is saved as you go, so you can stop and return to the quiz anytime.
Compare Your ResultsSee how your performance compares with your peers after each answer is submitted.
Earn PointsPoints are awarded for each correct answer.
Members Only FeaturesIf you're a member, you can track your progress and view the quizzes you've completed.
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.